These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29484136)

  • 1.
    Francis JC; Capper A; Ning J; Knight E; de Bono J; Swain A
    Oncotarget; 2018 Jan; 9(7):7604-7615. PubMed ID: 29484136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer.
    Christin JR; Wang C; Chung CY; Liu Y; Dravis C; Tang W; Oktay MH; Wahl GM; Guo W
    Cell Rep; 2020 Jun; 31(10):107742. PubMed ID: 32521267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation.
    Thomsen MK; Ambroisine L; Wynn S; Cheah KS; Foster CS; Fisher G; Berney DM; Møller H; Reuter VE; Scardino P; Cuzick J; Ragavan N; Singh PB; Martin FL; Butler CM; Cooper CS; Swain A;
    Cancer Res; 2010 Feb; 70(3):979-87. PubMed ID: 20103652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
    Mierke CT
    Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
    Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
    Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.
    Nouri M; Massah S; Caradec J; Lubik AA; Li N; Truong S; Lee AR; Fazli L; Ramnarine VR; Lovnicki JM; Moore J; Wang M; Foo J; Gleave ME; Hollier BG; Nelson C; Collins C; Dong X; Buttyan R
    Clin Cancer Res; 2020 Apr; 26(7):1678-1689. PubMed ID: 31919137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis.
    Liu Y; Zhuo S; Zhou Y; Ma L; Sun Z; Wu X; Wang XW; Gao B; Yang Y
    J Hepatol; 2022 Mar; 76(3):652-664. PubMed ID: 34793870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASCL1 represses a SOX9
    Olsen RR; Ireland AS; Kastner DW; Groves SM; Spainhower KB; Pozo K; Kelenis DP; Whitney CP; Guthrie MR; Wait SJ; Soltero D; Witt BL; Quaranta V; Johnson JE; Oliver TG
    Genes Dev; 2021 Jun; 35(11-12):847-869. PubMed ID: 34016693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rare castration-resistant progenitor cell population is highly enriched in Pten-null prostate tumours.
    Sackmann Sala L; Boutillon F; Menara G; De Goyon-Pélard A; Leprévost M; Codzamanian J; Lister N; Pencik J; Clark A; Cagnard N; Bole-Feysot C; Moriggl R; Risbridger GP; Taylor RA; Kenner L; Guidotti JE; Goffin V
    J Pathol; 2017 Sep; 243(1):51-64. PubMed ID: 28603917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers.
    Burdelski C; Bujupi E; Tsourlakis MC; Hube-Magg C; Kluth M; Melling N; Lebok P; Minner S; Koop C; Graefen M; Heinzer H; Wittmer C; Sauter G; Wilczak W; Simon R; Schlomm T; Steurer S; Krech T
    PLoS One; 2015; 10(6):e0128525. PubMed ID: 26030748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion.
    Wang H; Leav I; Ibaragi S; Wegner M; Hu GF; Lu ML; Balk SP; Yuan X
    Cancer Res; 2008 Mar; 68(6):1625-30. PubMed ID: 18339840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.
    Cheng PF; Shakhova O; Widmer DS; Eichhoff OM; Zingg D; Frommel SC; Belloni B; Raaijmakers MI; Goldinger SM; Santoro R; Hemmi S; Sommer L; Dummer R; Levesque MP
    Genome Biol; 2015 Feb; 16(1):42. PubMed ID: 25885555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-induced programs for prostate epithelial growth and invasion arise in embryogenesis and are reactivated in cancer.
    Schaeffer EM; Marchionni L; Huang Z; Simons B; Blackman A; Yu W; Parmigiani G; Berman DM
    Oncogene; 2008 Dec; 27(57):7180-91. PubMed ID: 18794802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collapsin response mediator protein-1 (CRMP1) acts as an invasion and metastasis suppressor of prostate cancer via its suppression of epithelial-mesenchymal transition and remodeling of actin cytoskeleton organization.
    Cai G; Wu D; Wang Z; Xu Z; Wong KB; Ng CF; Chan FL; Yu S
    Oncogene; 2017 Jan; 36(4):546-558. PubMed ID: 27321179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression.
    Carrasco-Garcia E; Lopez L; Moncho-Amor V; Carazo F; Aldaz P; Collado M; Bell D; Gaafar A; Karamitopoulou E; Tzankov A; Hidalgo M; Rubio Á; Serrano M; Lawrie CH; Lovell-Badge R; Matheu A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer.
    Tripathi SK; Biswal BK
    Life Sci; 2021 Jul; 277():119608. PubMed ID: 33989664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma.
    Shen Z; Deng H; Fang Y; Zhu X; Ye GT; Yan L; Liu H; Li G
    Oncotarget; 2015 Aug; 6(24):20672-84. PubMed ID: 26009899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
    Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
    Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells.
    Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X
    Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E-cadherin plasticity in prostate cancer stem cell invasion.
    Bae KM; Parker NN; Dai Y; Vieweg J; Siemann DW
    Am J Cancer Res; 2011; 1(1):71-84. PubMed ID: 21968440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.